Prathama Blood Centre

Prathama Blood Centre is a nonprofit blood centre based in Ahmedabad, Gujarat, India. The centre was jointly established in 2000 by the Ahmedabad Municipal Corporation and the Advanced Transfusion Medicine Research Foundation. Its name derives from the Sanskrit word for “first,” and its institutional purpose is centered on the collection, testing, processing, and distribution of blood and blood components for transfusion use. Prathama is described as India’s first fully automated blood centre. Automation is central to its operating model: the facility was designed to process donations and blood components at substantial scale while supporting standardized testing and handling procedures. The centre’s stated design capacity is modular and expandable to approximately 150,000 units of blood per year. Reference material reports that roughly 125,000 units of blood and blood components are distributed annually and that approximately 50,000 donors contribute blood each year. These figures indicate an organization whose role extends beyond a conventional local blood bank to a coordinated collection and distribution service. A major focus of Prathama’s work is transfusion safety. In 2016, on World Thalassemia Day, the centre introduced nucleic acid testing, commonly known as NAT, for donated blood. NAT is intended to identify certain transfusion-transmitted infections during periods when conventional testing may not yet detect an infection. By reducing the risk associated with window-period infections, the testing program is particularly relevant to people who require repeated transfusions, including patients living with thalassemia. Prathama also launched its Thalassemia Eradication Program in January 2009. The program reflects the centre’s broader public-health orientation: safe and reliable blood supplies are especially important in India, where thalassemia creates continuing demand for transfusions. The centre’s adoption of NAT and its thalassemia-focused activities position it as both a blood-service provider and a participant in efforts to improve transfusion medicine and patient outcomes. The organization’s public identity is therefore based less on consumer branding than on institutional trust, technical capability, donor participation, and access to safe blood. Its principal stakeholders include voluntary donors, hospitals, transfusion-dependent patients, public authorities, and medical organizations. No public information in the supplied references establishes a commercial parent company, stock-market listing, or international operating network. Prathama is best understood as an India-based nonprofit healthcare and transfusion-service institution operating from Ahmedabad.

Prathama Blood Centre was jointly established in Ahmedabad in 2000 by the Ahmedabad Municipal Corporation and the Advanced Transfusion Medicine Research Foundation. It was created as a nonprofit organization serving the blood-collection and transfusion needs of the surrounding community and wider healthcare system. The centre’s name, Prathama, comes from a Sanskrit term meaning “first.” From its foundation, the institution was organized around a high-throughput and technology-oriented model rather than a small standalone blood bank. It became known as India’s first fully automated blood centre. Its facility was designed on a modular basis, allowing capacity to expand as collection and distribution requirements increased. The stated design capacity is approximately 150,000 units of blood per year. Reference material also reports annual donations from about 50,000 people and yearly distribution of approximately 125,000 units of blood and blood components. The centre’s development has included a specific emphasis on transfusion safety. Blood intended for transfusion must be screened for risks associated with transfusion-transmitted infections, and the reliability of this screening is particularly important for people who receive blood repeatedly. Prathama’s work has therefore combined donor recruitment with laboratory testing, blood-component preparation, and distribution to clinical users. In January 2009, Prathama launched its Thalassemia Eradication Program. The initiative addressed a major public-health issue in India, where thalassemia creates a recurring need for safe blood supplies. Thalassemia patients may require regular transfusions, making the quality and availability of screened blood especially consequential. The program placed the centre’s transfusion infrastructure within a broader disease-focused and preventive-health context. On World Thalassemia Day in 2016, Prathama introduced nucleic acid testing, or NAT, for donated blood. NAT is designed to detect genetic material associated with certain infections and can help identify some infections during the window period before they are detectable through other screening approaches. The centre’s use of NAT was described as a measure to reduce the risk of transfusion-transmitted infections for recipients, with particular relevance to patients receiving repeated transfusions. Taken together, the centre’s history reflects a progression from institutional establishment to expanded automated operations, disease-focused programming, and more advanced infectious-disease screening. Its public role is that of a nonprofit transfusion-medicine organization in Ahmedabad, supported by voluntary blood donation and connected to the wider Indian healthcare system. The supplied reference material does not identify a commercial parent, listed securities, senior executives, or operations outside India.

• 2016

  Nucleic acid testing is introduced

  [1]Prathama Blood Centreen.wikipedia.org

  The centre introduces NAT screening for donated blood on World Thalassemia Day to improve detection of transfusion-transmitted infections.

• 2009

  Thalassemia Eradication Program begins

  [1]Prathama Blood Centreen.wikipedia.org

  Prathama launches a program addressing the transfusion and public-health needs associated with thalassemia.

• 2000

  Prathama Blood Centre is established

  [1]Prathama Blood Centreen.wikipedia.org

  The Ahmedabad Municipal Corporation and the Advanced Transfusion Medicine Research Foundation jointly establish Prathama Blood Centre as a nonprofit organization.

A nonprofit, technology-enabled blood centre focused on safe transfusion, large-scale donor collection, blood-component distribution, and support for patients who require recurring transfusions.

• Blood products · 2000

  Whole blood and blood components

  Prathama collects donated blood and distributes blood and blood components for transfusion use. The centre is reported to distribute approximately 125,000 units annually and was designed with modular capacity for up to about 150,000 units per year. The available references do not provide a complete component-by-component product catalogue.

• Transfusion safety testing · 2016

  Nucleic acid testing

  Introduced in 2016, NAT is used to screen donated blood for evidence of certain infections at an earlier stage than some conventional testing methods may allow. Its purpose at Prathama is to reduce the risk of transfusion-transmitted infections, including those associated with window-period infections.

• Public-health and transfusion support program · 2009

  Thalassemia Eradication Program

  Launched in January 2009, this program focuses on the blood-supply and transfusion implications of thalassemia. It forms part of Prathama’s broader public-health role and supports the importance of safe, consistently available blood for patients who require regular transfusions.

• 2016

  Adoption of nucleic acid testingProduct launch

  Background

  Recipients of donated blood can face risks from transfusion-transmitted infections, including infections that may not yet be detectable through some conventional screening methods. This issue is especially important for patients needing repeated transfusions.

  Action taken

  Prathama introduced NAT screening for donated blood on World Thalassemia Day, adding a molecular testing approach intended to improve detection during the window period.

  Aftermath

  The initiative strengthened the centre’s stated focus on transfusion safety and was particularly relevant to thalassemia patients and other recurring transfusion recipients.

  Source

• 2009

  Launch of the Thalassemia Eradication ProgramStrategy

  Background

  Thalassemia creates an ongoing need for safe blood among patients requiring regular transfusions, making blood-centre operations directly relevant to disease management and public health.

  Action taken

  Prathama established a dedicated program addressing thalassemia and its transfusion-related needs.

  Aftermath

  The program broadened Prathama’s role from blood collection and distribution toward disease-focused transfusion support.

  Source

1. 1Prathama Blood Centreen.wikipedia.org
2. 2Prathama Blood Centre official websiteprathama.org